Literature DB >> 35557037

Therapeutic potential of traditional Chinese medicine for vascular endothelial growth factor.

Yijia Mao1, Lingkai Meng1, Huayi Liu2, Yuting Lu1, Kuo Yang3, Guangze Ouyang1, Yanran Ban1, Shuang Chen1.   

Abstract

Vascular endothelial growth factor (VEGF) is the main regulator of physiological angiogenesis during embryonic development, bone growth, and reproductive function, and it also participates in a series of pathological changes. Traditional Chinese medicine (TCM), with a history of more than 2000 years, has been widely used in clinical practice, while the exploration of its mechanisms has only begun. This review summarizes the research of recent years on the influence of TCM on VEGF. It is found that many Chinese medicines and recipes have a regulatory effect on VEGF, indicating that Chinese medicine has broad prospects as a complementary and alternative therapy, providing new treatment ideas for clinical applications and the theoretical basis for research on the mechanisms of TCM.

Entities:  

Keywords:  Traditional Chinese medicine (TCM); VEGF receptor; Vascular endothelial growth factor (VEGF)

Mesh:

Substances:

Year:  2022        PMID: 35557037      PMCID: PMC9110323          DOI: 10.1631/jzus.B2101055

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   5.552


  76 in total

1.  Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema.

Authors:  R J Kaner; J V Ladetto; R Singh; N Fukuda; M A Matthay; R G Crystal
Journal:  Am J Respir Cell Mol Biol       Date:  2000-06       Impact factor: 6.914

Review 2.  Critical role of hypoxia sensor--HIF-1α in VEGF gene activation. Implications for angiogenesis and tissue injury healing.

Authors:  A Ahluwalia; A S Tarnawski
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

3.  Anti-angiogenic effect of tanshinone IIA involves inhibition of the VEGF/VEGFR2 pathway in vascular endothelial cells.

Authors:  Yingying Xing; Jiajie Tu; Lufeng Zheng; Le Guo; Tao Xi
Journal:  Oncol Rep       Date:  2014-11-07       Impact factor: 3.906

Review 4.  VEGF: an essential mediator of both angiogenesis and endochondral ossification.

Authors:  J Dai; A B M Rabie
Journal:  J Dent Res       Date:  2007-10       Impact factor: 6.116

5.  Danggui Buxue decoction promotes angiogenesis by up-regulation of VEGFR1/2 expressions and down-regulation of sVEGFR1/2 expression in myocardial infarction rat.

Authors:  Guanying Hu; Peng Yang; Yu Zeng; Sanyin Zhang; Jiage Song
Journal:  J Chin Med Assoc       Date:  2017-09-04       Impact factor: 2.743

Review 6.  Clinical implications for vascular endothelial growth factor in the lung: friend or foe?

Authors:  Andriana I Papaioannou; Konstantinos Kostikas; Panagoula Kollia; Konstantinos I Gourgoulianis
Journal:  Respir Res       Date:  2006-10-17

7.  Exploration of the Modulatory Property Mechanism of ELeng Capsule in the Treatment of Endometriosis Using Transcriptomics Combined With Systems Network Pharmacology.

Authors:  Weilin Zheng; Jie Wang; Jiayi Wu; Tao Wang; Yangxue Huang; Xuefang Liang; Lixing Cao
Journal:  Front Pharmacol       Date:  2021-06-18       Impact factor: 5.810

8.  Xijiao Dihuang Decoction Alleviates Ischemic Brain Injury in MCAO Rats by Regulating Inflammation, Neurogenesis, and Angiogenesis.

Authors:  Xiaojun Fei; Xu Zhang; Qi Wang; Jingbo Li; Hao Shen; Xuanye Wang; Hongquan Liu; Weiwei Tao
Journal:  Evid Based Complement Alternat Med       Date:  2018-06-25       Impact factor: 2.629

9.  Deciphering the Pharmacological Mechanisms of Taohe-Chengqi Decoction Extract Against Renal Fibrosis Through Integrating Network Pharmacology and Experimental Validation In Vitro and In Vivo.

Authors:  Shanshan Zhou; Zhongzhu Ai; Weinan Li; Pengtao You; Chaoyan Wu; Liang Li; Yuanyang Hu; Yuanming Ba
Journal:  Front Pharmacol       Date:  2020-04-16       Impact factor: 5.810

10.  Xiaoyaosan, a traditional Chinese medicine, inhibits the chronic restraint stress-induced liver metastasis of colon cancer in vivo.

Authors:  Lu Zhao; Xiaodan Zhu; Yiqun Ni; Jianliang You; Ao Li
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.